awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40409656-3DF3A99E-0650-4BCD-91D8-EF47E63AD3A8
Q40409656-3DF3A99E-0650-4BCD-91D8-EF47E63AD3A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40409656-3DF3A99E-0650-4BCD-91D8-EF47E63AD3A8
18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.
P2860
Q40409656-3DF3A99E-0650-4BCD-91D8-EF47E63AD3A8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40409656-3DF3A99E-0650-4BCD-91D8-EF47E63AD3A8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
714f507cc5e9ddcb641855c7ffba53bd4bf74ee7
P2860
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.